During the last session, Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s traded shares were 0.32 million, with the beta value of the company hitting 0.21. At the end of the trading day, the stock’s price was $0.78, reflecting an intraday gain of 10.35% or $0.07. The 52-week high for the RVPH share is $4.28, that puts it down -448.72 from that peak though still a striking 37.18% gain since the share price plummeted to a 52-week low of $0.49. The company’s market capitalization is $36.57M, and the average intraday trading volume over the past 10 days was 0.69 million shares, and the average trade volume was 1.16 million shares over the past three months.
Reviva Pharmaceuticals Holdings Inc (RVPH) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. RVPH has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.18.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) trade information
Reviva Pharmaceuticals Holdings Inc (RVPH) registered a 10.35% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.35% in intraday trading to $0.78, hitting a weekly high. The stock’s 5-day price performance is 34.97%, and it has moved by -26.88% in 30 days. Based on these gigs, the overall price performance for the year is -76.50%. The short interest in Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) is 2.92 million shares and it means that shorts have 4.45 day(s) to cover.
While earnings are projected to return 20.37% in 2025, the next five years will return 21.52% per annum.
RVPH Dividends
Reviva Pharmaceuticals Holdings Inc is due to release its next quarterly earnings on 2025-Mar-30. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s Major holders
Reviva Pharmaceuticals Holdings Inc insiders own 10.58% of total outstanding shares while institutional holders control 21.82%, with the float percentage being 24.40%. WOODLINE PARTNERS LP is the largest shareholder of the company, while 46.0 institutions own stock in it. As of 2024-06-30, the company held over 1.59 million shares (or 5.2129% of all shares), a total value of $2.04 million in shares.
The next largest institutional holding, with 1.03 million shares, is of VANGUARD GROUP INC’s that is approximately 4.2659% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.31 million.
